Togo Jose M, Hurtado Thania M
Department of Laser, Regenerative, and Functional Gynecology, Central Medica Quirurgica, Mazatlan, MEX.
Department of Gynecologic Oncology, Central Médica Quirúrgica, Mazatlan, MEX.
Cureus. 2024 Dec 19;16(12):e75990. doi: 10.7759/cureus.75990. eCollection 2024 Dec.
Background Female sexual dysfunction (FSD) affects a significant portion of the female population, negatively impacting quality of life. New therapeutic approaches, such as the combination of laser therapy and platelet-rich plasma (PRP), are being explored as potential treatments to enhance sexual function in affected women. Methods This original study involved 23 women aged 37 to 72, all diagnosed with varying degrees of FSD (mild, moderate, severe). The participants underwent a pre-treatment evaluation using a custom-designed Likert scale (Female Sexual Health Questionnaire) designed by the authors to evaluate the symptoms of the patients. The treatment involved a single session combining hybrid carbon dioxide 10600 nm and 1540 nm laser therapy with PRP applied to the genital area. One month post-treatment, participants were reassessed using the same questionnaire. Results Of the 23 patients studied, 65.2% (15 patients) exhibited hypoactive sexual desire, and 73.33% of them (11 out of 15) demonstrated improvement post-treatment (P = 0.00048). Overall sexual satisfaction increased by 28.2% (P = 0.0032), and lubrication improved in 54.5% of patients (P = 0.0027). Significant reductions in dyspareunia were observed, with 80% of patients experiencing pain relief (P = 0.0035). Patients with moderate dysfunction showed the highest response, with 100% (6 out of 6) demonstrating improvement across domains (P = 0.0009). Postmenopausal women experienced a 30.9% improvement in sexual function (P = 0.007), while premenopausal women exhibited a 7.5% improvement (P = 0.04). Statistically significant changes were also noted in the frequency of orgasm (P = 0.0058) and genital sensitivity in patients with moderate dysfunction. Conclusion Our data indicated significant improvements in FSD, particularly in moderate to severe dysfunction, with positive changes in key aspects of sexual function such as lubrication, desire, and ease of orgasm. However, the limited number of participants and short follow-up in this pilot study highlight the need for further investigation into hybrid CO2/1540 nm laser therapy combined with PRP as a therapeutic option for female sexual dysfunction.
背景 女性性功能障碍(FSD)影响着相当一部分女性群体,对生活质量产生负面影响。诸如激光疗法与富血小板血浆(PRP)联合使用等新的治疗方法正在被探索,作为增强受影响女性性功能的潜在治疗手段。方法 这项原创研究纳入了23名年龄在37至72岁之间的女性,她们均被诊断为不同程度的FSD(轻度、中度、重度)。参与者使用作者设计的定制李克特量表(女性性健康问卷)进行治疗前评估,以评估患者的症状。治疗包括将10600 nm和1540 nm混合二氧化碳激光疗法与PRP联合应用于生殖器区域的单次治疗。治疗后1个月,使用相同问卷对参与者进行重新评估。结果 在研究的23名患者中,65.2%(15名患者)表现为性欲减退,其中73.33%(15名中的11名)在治疗后表现出改善(P = 0.00048)。总体性满意度提高了28.2%(P = 0.0032),54.5%的患者润滑情况得到改善(P = 0.0027)。观察到性交疼痛显著减轻,80%的患者疼痛缓解(P = 0.0035)。中度功能障碍患者的反应最为明显,100%(6名中的6名)在各个方面均表现出改善(P = 0.0009)。绝经后女性性功能改善了30.9%(P = 0.007),而绝经前女性改善了7.5%(P = 0.04)。中度功能障碍患者的性高潮频率(P = 0.0058)和生殖器敏感度也出现了具有统计学意义的变化。结论 我们的数据表明FSD有显著改善,尤其是在中度至重度功能障碍方面,性功能的关键方面如润滑、性欲和性高潮的难易程度都有积极变化。然而,这项初步研究中参与者数量有限且随访时间短,凸显了有必要进一步研究混合二氧化碳/1540 nm激光疗法联合PRP作为女性性功能障碍治疗选择的可行性。